Other
Butyrophenone, 4'-fluoro-4-(4-(o-methoxyphenyl)-1-piperazinyl)-, hydrochloride
Safety score · 0–100
Avoid
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
A cosmetic ingredient used in product formulations. Its specific function may vary between products. Exercise caution due to limited available safety data.
This is a butyrophenone derivative with structural features characteristic of typical antipsychotic agents (haloperidol-like). The butyrophenone pharmacophore combined with the piperazinyl-methoxyphenyl substituent creates a molecule with dopamine receptor affinity and CNS activity. Butyrophenone antipsychotics are pharmacologically active substances with effects on the central nervous system. EU Cosmetics Regulation prohibits such substances from cosmetic formulations as they are not intended for mere skin conditioning but rather alter physiological function.
Known concerns
- Butyrophenone antipsychotic pharmacophore
- CNS-active pharmaceutical substance
- Prohibited from cosmetic use under EU regulations
- Dopamine receptor binding activity
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related others
Check your shelf
Find Butyrophenone, 4'-fluoro-4-(4-(o-methoxyphenyl)-1-piperazinyl)-, hydrochloride in your products.
Scan any cosmetic product with LuxSense to see if it contains Butyrophenone, 4'-fluoro-4-(4-(o-methoxyphenyl)-1-piperazinyl)-, hydrochloride and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.